Purebase sets $150K salary for new CFO

Q: What executive compensation did Purebase (PUBC) approve in this 8-K?

Purebase’s board approved annual compensation of $150,000 for its Chief Financial Officer, Dr. Amy T. Clemens. The amount will be paid under the company’s normal payroll practices, indicating a structured, salaried role rather than one-time or transaction-based compensation.

Q: When did Purebase (PUBC) appoint Dr. Amy T. Clemens as CFO?

Dr. Amy T. Clemens was appointed as Purebase’s Chief Financial Officer on June 4, 2026. The June 17, 2026 board action in this filing follows that earlier appointment and focuses specifically on approving her ongoing annual compensation level of $150,000.

Q: When did Purebase’s board approve the CFO’s $150,000 compensation?

Purebase’s board approved the $150,000 annual compensation for CFO Dr. Amy T. Clemens on June 17, 2026. This decision came after her June 4, 2026 appointment, aligning her pay with the company’s standard payroll schedule and formalizing her compensation package.

Q: How will the new Purebase CFO’s $150,000 salary be paid?

The $150,000 annual compensation for Purebase’s CFO will be paid under the company’s regular payroll practices. This means the salary is expected to be spread across standard pay periods, consistent with how other employees and executives are typically compensated.

Q: What SEC item does this Purebase (PUBC) filing relate to?

The filing relates to Item 5.02, covering departure or appointment of certain officers and related compensation arrangements. In this case, the focus is on confirming the compensation terms for newly appointed Chief Financial Officer Dr. Amy T. Clemens at $150,000 annually.

Purebase Corporation disclosed that its board has set the annual compensation for newly appointed Chief Financial Officer Dr. Amy T. Clemens at $150,000.

Filing Impact

(High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Purebase Corporation disclosed that its board has set the annual compensation for newly appointed Chief Financial Officer Dr. Amy T. Clemens at $150,000. The compensation will be paid according to the company’s regular payroll practices. Dr. Clemens was appointed CFO on June 4, 2026, and the pay decision followed on June 17, 2026.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

CFO annual compensation: $150,000 CFO appointment date: June 4, 2026 Commission File Number: 000-55517

3 metrics

CFO annual compensation $150,000 Annual salary approved for CFO on June 17, 2026

CFO appointment date June 4, 2026 Date Dr. Amy T. Clemens was appointed CFO

Commission File Number 000-55517 Purebase Corporation SEC file reference

Key Terms

Emerging growth company, Chief Financial Officer, annual compensation

3 terms

Emerging growth company regulatory

"Emerging growth company Item 5.02 Departure of Directors or Certain Officers"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Chief Financial Officer financial

"Dr. Amy T. Clemens was appointed to serve as Chief Financial Officer of the Company."

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

annual compensation financial

"the board of directors of the Company approved the payment of annual compensation of $150,000.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive compensation did Purebase (PUBC) approve in this 8-K?

Purebase’s board approved annual compensation of $150,000 for its Chief Financial Officer, Dr. Amy T. Clemens. The amount will be paid under the company’s normal payroll practices, indicating a structured, salaried role rather than one-time or transaction-based compensation.

When did Purebase (PUBC) appoint Dr. Amy T. Clemens as CFO?

Dr. Amy T. Clemens was appointed as Purebase’s Chief Financial Officer on June 4, 2026. The June 17, 2026 board action in this filing follows that earlier appointment and focuses specifically on approving her ongoing annual compensation level of $150,000.

When did Purebase’s board approve the CFO’s $150,000 compensation?

Purebase’s board approved the $150,000 annual compensation for CFO Dr. Amy T. Clemens on June 17, 2026. This decision came after her June 4, 2026 appointment, aligning her pay with the company’s standard payroll schedule and formalizing her compensation package.

How will the new Purebase CFO’s $150,000 salary be paid?

The $150,000 annual compensation for Purebase’s CFO will be paid under the company’s regular payroll practices. This means the salary is expected to be spread across standard pay periods, consistent with how other employees and executives are typically compensated.

What SEC item does this Purebase (PUBC) filing relate to?

The filing relates to Item 5.02, covering departure or appointment of certain officers and related compensation arrangements. In this case, the focus is on confirming the compensation terms for newly appointed Chief Financial Officer Dr. Amy T. Clemens at $150,000 annually.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/22/2026 - 03:01 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): June 17, 2026

PUREBASE CORPORATION

(Exact name of registrant as specified in its charter)

Nevada

000-55517

27-2060863

(State or other jurisdiction of

incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

14110 Ridge Road

Sutter Creek, California 95685

(Address of principal executive offices)

(209) 991-2180

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of exchange on which registered
None		N/A		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously reported in the Current Report on Form 8-K of Purebase Corporation (the “Company”), on June 4, 2026, Dr. Amy T. Clemens was appointed to serve as Chief Financial Officer of the Company. On June 17, 2026, the board of directors of the Company approved the payment of annual compensation of $150,000.00 to Dr. Clemens in accordance with the regular payroll practices of the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PUREBASE CORPORATION

Dated: June 22, 2026	By:	/s/ A. Scott Dockter
		A. Scott Dockter
		Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents